Study to examine the effects of Salmeterol/fluticasone propionate combination(SFC) in patients with cough variant asthma(CVA)
Phase 4
- Conditions
- Cough variant asthma
- Registration Number
- JPRN-UMIN000002390
- Lead Sponsor
- Kyoto University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients without cough symptom in the last 1 week before enrollment 2)Patients with other respiratory diseases 3)Patients taking Long acting be-ta 2 agonist(LABA) or Leukotriene receptor antagonist(LTRA) 4)Patients who are given systemic corticosteroid in the last 4 weeks 5)Patients who suffered from upper respiratory infection in the last 4 weeks 6)Patients who had smoked in the last 6 months, or who had smoked more than 10 pack year in the past 7)Patients who are considered inappropriate by physicians in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method